By Adam Bonislawski
Vermillion said this week that it sold more than 3,000 of its OVA1 ovarian cancer tests in the first quarter and generated $431,000 in total revenue, compared to revenue of $73,000 in Q1 2010.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now. Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
In Nature this week: genomic analysis of 200 bird species, and more.
The Australian High Court rules that isolated genetic material cannot be patented.
The startup incubator Y Combinator is launching a nonprofit research lab.
In Genome Research this week: vervet genome, tandem repeats affect gene expression in great apes, and more.